QQ客服 官方微博 反馈留言

	HDAC Inhibitors Lead to Significant Survival Benefit in a Novel Fusion Protein TBLR1-Rara Induced Murine Promyelocytic Leukemia Model
	Li, Shouyun; Liu, Shuang; Chen, Shuying; Chen, Yirui; Wang, Ying; Chen, Liping; Tian, Zheng; Xing, Haiyan; Tang, Kejing; Xu, Yingxi
	2016
卷号	128期号:22
ISSN号	0006-4971
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6385437
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Li, Shouyun,Liu, Shuang,Chen, Shuying,et al. HDAC Inhibitors Lead to Significant Survival Benefit in a Novel Fusion Protein TBLR1-Rara Induced Murine Promyelocytic Leukemia Model[J],2016,128(22).
APA	Li, Shouyun.,Liu, Shuang.,Chen, Shuying.,Chen, Yirui.,Wang, Ying.,...&Wang, Jianxiang.(2016).HDAC Inhibitors Lead to Significant Survival Benefit in a Novel Fusion Protein TBLR1-Rara Induced Murine Promyelocytic Leukemia Model.,128(22).
MLA	Li, Shouyun,et al."HDAC Inhibitors Lead to Significant Survival Benefit in a Novel Fusion Protein TBLR1-Rara Induced Murine Promyelocytic Leukemia Model".128.22(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。